AI Master - Online advanced study at the University of Lübeck

Looking to improve your career opportunities in the rapidly evolving field of AI?

The University of Lübeck is offering a new online master's program in artificial intelligence as advanced study for technical professionals who already have experience in computer science or other technical disciplines and want to further their education in the field of artificial intelligence.

Reach out to artificial intelligence and improve your career opportunities in robotics, medical technology and many other fields!
You want to become an "AI Master"? Then the University of Lübeck has the right offer for you! (Image: @ Possessed Photography/unsplash)

Artificial intelligence (AI) is the central principle for the disruptive changes of the digital transformation – in industry, the public sector and our society. AI is the driving force in today’s systems development and process innovation.

To be an active part of this change, you want to fully understand the key principles and techniques forming AI.

The advanced study program Artificial Intelligence (AI) Master is free of charge and can be completed on a part-time basis. Required are at least one year of relevant full-time work experience, a first university degree in computer science, engineering or a comparable field, as well as basic mathematical knowledge at university level and programming skills.

Start of study is 16.10.2023

More News

Onco AI-Med meeting at Indivumed: Dr. David Kerr, Nils Schumacher, Prof. Gerry Melino, Nina Gabelia, Dr. John Marshall, Dr. Takayuki Yoshino, Prof. Hartmut Juhl, Dr. Sun Young Rha, Dr. Jesus Garcia-Foncillas, Dr. Carlos Sampaio and Dr. David Gallagher (fr
Onco AI-Med meeting at Indivumed: Dr. David Kerr, Nils Schumacher, Prof. Gerry Melino, Nina Gabelia, Dr. John Marshall, Dr. Takayuki Yoshino, Prof. Hartmut Juhl, Dr. Sun Young Rha, Dr. Jesus Garcia-Foncillas, Dr. Carlos Sampaio and Dr. David Gallagher (from left to right) (Picture: Indivumed)

Indivumed Hosts Onco AI-Med Annual Board Meeting in Hamburg

Indivumed Therapeutics (“Indivumed”) welcomed members of the Oncology Alliance For Individualized Medicine (“Onco AI-Med”) to its global headquarters in Hamburg, ...

Read more …
Indivumed is using nRavel™ for target discovery and drug development programs. (Picture: ©Jackie Niam/stock.adobe.com)

Indivumed Launches the nRavel AI Platform

Indivumed GmbH (“Indivumed”) today announced the launch of nRavel™, a unique AI discovery platform for oncology and precision medicine. The platform combines ...

Read more …